Value & Access
teams at Pharma.
Evidence generation, evidence synthesis and value communication, harnessing the power of AI.
Global Clients
20+
Projects
300+
Publications
126+
Therapeutic Areas
30+
Conferences
20+
Innovative Therapies
25+
Tailored solutions for value demonstration of your innovative therapy, delivered by AI-powered subject matter experts.
Working together. Learning together. Thriving together.
PharmaQuant Consulting.
Health Economic Modelling
Evidence Synthesis
Advanced Analytics
Value Communication
Training and Workshops
Integrated end-to-end HEVA solutions.
Opportunity Assessment
- Disease landscape & unmet-need assessment
- Epidemiology estimation & burden of illness scan
- Pricing potential & access risk assessment
- Early value driver framework
Phase 1
- Targeted literature reviews (TLR)
- Target value proposition development
- HEOR & HTA strategic planning
- Integrated evidence roadmap & sequencing
- Phase 2 trial design support
Phase 2
- Systematic literature reviews (living)
- COA / PRO & endpoint strategy
- Early scientific advice support
- Early health economic models
- ITC/NMA feasibility
- RWE data landscaping
- Phase 3 trial design support
- Publication planning
Phase 3
- SLR updates
- ITCs including MAIC / STC
- NMA, survival extrapolation
- HEOR & HTA statistical analysis plan (SAP) and analyses
- HTA ready health economic models
- Global value dossier development
- Advisory boards & mock appraisals
- Congress abstracts, posters & manuscripts
Read-out & Pre-Launch
- Value dossier finalisation & objection handlers
- HTA submission preparation & expert review
- Payer research & value message testing
- Launch congress & publication programme
Launch & Post-Launch
- HTA response & post-submission support
- Competitor HTA monitoring & comparator refresh
- Tier 2/3 market adaptations, updates & indication expansion models
- RWE publications & ongoing value communication
PharmaQuant AI Applied Sciences.
AI-Driven Enterprise ready solutions that help you demonstrate Payer Value Proposition, enable Market Access and improve chances of successful reimbursements across geographies.
Fast and Accurate Systematic Reviews
AI-powered platform to identify relevant evidence in minutes
Automated, AI enabled Network Meta Analysis for efficient evidence synthesis
Automated, AI enabled Health Economic Modelling in hours
Turn evidence into dashboards using AI Automation
Why trust PharmaQuant?
Evidence-Driven Strategy
Our multidisciplinary team delivers rigorous HEOR evidence that accelerates market access and informs reimbursement decisions globally
AI-Powered Solutions
Experience our revolutionary AI-driven literature review platform transforming how systematic reviews are conducted
Global HEOR Expertise
Leverage deep expertise in health economics, outcomes research, and real-world evidence across therapeutic areas and geographies
Patient-Centred Research
We place patients at the centre of every analysis, ensuring evidence reflects real-world outcomes and quality of life impacts
Collaborative Partnership
We work as an extension of your team, offering flexible engagement models tailored to your strategic goals and timelines
Schedule a meeting.
Stay up to date with the latest news, announcements, and articles
PharmaQuant on LinkedIn (opens in a new tab)